Supplementary Figure S3 from An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers

<p>Supplementary Figure S3 shows in A the CD10 transcript expression level in various cancer types from the TCGA cohorts. B shows the expression level of the CD10 protein in various cancer types from the human protein atlas. C shows the progression free intervals in function of the ENI10 score of various cancer types from the TCGA cohorts. D shows the ENI10 score of cohorts of benign melanocytic nevi or primary melanoma.</p>